Found: 54
Select item for more details and to access through your institution.
Suspected Methotrexate Toxicity From Omeprazole: A Case Review of Carboxypeptidase G2 Use in a Methotrexate-Experienced Patient With Methotrexate Toxicity and a Review of the Literature.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Lung tumor NF-κB signaling promotes T cell-mediated immune surveillance.
- Published in:
- Journal of Clinical Investigation, 2013, v. 123, n. 6, p. 2509, doi. 10.1172/JCI67250
- By:
- Publication type:
- Article
An immunoproteomic approach to characterize the CAR interactome and signalosome.
- Published in:
- Science Signaling, 2019, v. 12, n. 568, p. N.PAG, doi. 10.1126/scisignal.aap9777
- By:
- Publication type:
- Article
The neuropilin 2 isoform NRP2b uniquely supports TGFβ-mediated progression in lung cancer.
- Published in:
- Science Signaling, 2017, v. 10, n. 462, p. 1, doi. 10.1126/scisignal.aag0528
- By:
- Publication type:
- Article
Coupling an EML4-ALK-centric interactome with RNA interference identifies sensitizers to ALK inhibitors.
- Published in:
- Science Signaling, 2016, v. 9, n. 450, p. 1, doi. 10.1126/scisignal.aaf5011
- By:
- Publication type:
- Article
New twists in the AXL(e) of tumor progression.
- Published in:
- Science Signaling, 2016, v. 9, n. 448, p. 1, doi. 10.1126/scisignal.aai7619
- By:
- Publication type:
- Article
Annotation of human cancers with EGFR signaling-associated protein complexes using proximity ligation assays.
- Published in:
- Science Signaling, 2015, v. 8, n. 359, p. 1, doi. 10.1126/scisignal.2005906
- By:
- Publication type:
- Article
Cell signaling heterogeneity is modulated by both cell-intrinsic and -extrinsic mechanisms: An integrated approach to understanding targeted therapy.
- Published in:
- PLoS Biology, 2018, v. 16, n. 3, p. 1, doi. 10.1371/journal.pbio.2002930
- By:
- Publication type:
- Article
SHP2 inhibition displays efficacy as a monotherapy and in combination with JAK2 inhibition in preclinical models of myeloproliferative neoplasms.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 6, p. 1040, doi. 10.1002/ajh.27282
- By:
- Publication type:
- Article
Src Inhibitors in Lung Cancer: Current Status and Future Directions.
- Published in:
- Clinical Lung Cancer, 2010, v. 11, n. 4, p. 238, doi. 10.3816/CLC.2010.n.030
- By:
- Publication type:
- Article
Development of a Targeted Smoking Relapse-Prevention Intervention for Cancer Patients.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A Pilot Proteogenomic Study with Data Integration Identifies MCT1 and GLUT1 as Prognostic Markers in Lung Adenocarcinoma.
- Published in:
- PLoS ONE, 2015, v. 10, n. 10, p. 1, doi. 10.1371/journal.pone.0142162
- By:
- Publication type:
- Article
Transforming Growth Factor β Signaling Overcomes Dasatinib Resistance in Lung Cancer.
- Published in:
- PLoS ONE, 2014, v. 9, n. 12, p. 1, doi. 10.1371/journal.pone.0114131
- By:
- Publication type:
- Article
Characterizing Tyrosine Phosphorylation Signaling in Lung Cancer Using SH2 Profiling.
- Published in:
- PLoS ONE, 2010, v. 5, n. 10, p. 1, doi. 10.1371/journal.pone.0013470
- By:
- Publication type:
- Article
Relative protein quantification and accessible biology in lung tumor proteomes from four LC-MS/MS discovery platforms.
- Published in:
- Proteomics, 2017, v. 17, n. 6, p. n/a, doi. 10.1002/pmic.201600300
- By:
- Publication type:
- Article
Randomized-controlled phase II trial of salvage chemotherapy after immunization with a TP53-transfected dendritic cell-based vaccine (Ad.p53-DC) in patients with recurrent small cell lung cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 3, p. 517, doi. 10.1007/s00262-018-2287-9
- By:
- Publication type:
- Article
A phase I/randomized phase II study of GM.CD40L vaccine in combination with CCL21 in patients with advanced lung adenocarcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 12, p. 1853, doi. 10.1007/s00262-018-2236-7
- By:
- Publication type:
- Article
Stat3 regulates genes common to both wound healing and cancer.
- Published in:
- Oncogene, 2005, v. 24, n. 21, p. 3397, doi. 10.1038/sj.onc.1208469
- By:
- Publication type:
- Article
Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells.
- Published in:
- Oncogene, 2003, v. 22, n. 27, p. 4150, doi. 10.1038/sj.onc.1206479
- By:
- Publication type:
- Article
Direct repression of the Mcl-1 promoter by E2F1.
- Published in:
- Oncogene, 2002, v. 21, n. 9, p. 1359, doi. 10.1038/sj.onc.1205157
- By:
- Publication type:
- Article
K27-linked ubiquitination of BRAF by ITCH engages cytokine response to maintain MEK-ERK signaling.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41467-019-09844-0
- By:
- Publication type:
- Article
Utilization of target lesion heterogeneity for treatment efficacy assessment in late stage lung cancer.
- Published in:
- PLoS ONE, 2021, v. 16, n. 7, p. 1, doi. 10.1371/journal.pone.0252041
- By:
- Publication type:
- Article
Gene expression patterns that predict sensitivity to epidermal growth factor receptor tyrosine kinase inhibitors in lung cancer cell lines and human lung tumors.
- Published in:
- BMC Genomics, 2006, v. 7, p. 289, doi. 10.1186/1471-2164-7-289
- By:
- Publication type:
- Article
Differential Chemoproteomics Reveals MARK2/3 as Cell Migration‐Relevant Targets of the ALK Inhibitor Brigatinib.
- Published in:
- ChemBioChem, 2023, v. 24, n. 11, p. 1, doi. 10.1002/cbic.202200766
- By:
- Publication type:
- Article
Phase 2 Trial of Docetaxel and Gefitinib in the First-Line Treatment of Patients With Advanced Nonsmall-Cell Lung Cancer (NSCLC) Who Are 70 Years of Age or Older.
- Published in:
- Cancer (0008543X), 2008, v. 112, n. 9, p. 2021, doi. 10.1002/cncr.23360
- By:
- Publication type:
- Article
An essential role for Stat3 in regulating IgG immune complex-induced pulmonary inflammation.
- Published in:
- FASEB Journal, 2011, v. 25, n. 12, p. 4292, doi. 10.1096/fj.11-187955
- By:
- Publication type:
- Article
cAMP/CREB-regulated LINC00473 marks LKB1-inactivated lung cancer and mediates tumor growth.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Lowering Sample Requirements to Study Tyrosine Kinase Signaling Using Phosphoproteomics with the TMT Calibrator Approach.
- Published in:
- Proteomics, 2020, v. 20, n. 24, p. 1, doi. 10.1002/pmic.202000116
- By:
- Publication type:
- Article
Activity-Based Proteomics Reveals Heterogeneous Kinome and ATP-Binding Proteome Responses to MEK Inhibition in KRAS Mutant Lung Cancer.
- Published in:
- Proteomes, 2016, v. 4, n. 2, p. 16, doi. 10.3390/proteomes4020016
- By:
- Publication type:
- Article
Genome-wide interaction study of smoking behavior and non-small cell lung cancer risk in Caucasian population.
- Published in:
- Carcinogenesis, 2018, v. 39, n. 3, p. 336, doi. 10.1093/carcin/bgx113
- By:
- Publication type:
- Article
SHP2E76K mutant promotes lung tumorigenesis in transgenic mice.
- Published in:
- Carcinogenesis, 2014, v. 35, n. 8, p. 1717, doi. 10.1093/carcin/bgu025
- By:
- Publication type:
- Article
TNFRSF10B polymorphisms and haplotypes associated with increased risk of death in non-small cell lung cancer.
- Published in:
- Carcinogenesis, 2013, v. 34, n. 11, p. 2525, doi. 10.1093/carcin/bgt244
- By:
- Publication type:
- Article
MEK inhibitors block growth of lung tumours with mutations in ataxia-telangiectasia mutated.
- Published in:
- Nature Communications, 2016, v. 7, n. 12, p. 13701, doi. 10.1038/ncomms13701
- By:
- Publication type:
- Article
Phase 1 trial of dasatinib combined with afatinib for epidermal growth factor receptor- (EGFR-) mutated lung cancer with acquired tyrosine kinase inhibitor (TKI) resistance.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A phase I study of tasisulam sodium (LY573636 sodium), a novel anticancer compound in patients with refractory solid tumors.
- Published in:
- 2011
- By:
- Publication type:
- journal article
A small molecule pan-Bcl-2 family inhibitor, GX15-070, induces apoptosis and enhances cisplatin-induced apoptosis in non-small cell lung cancer cells.
- Published in:
- 2008
- By:
- Publication type:
- journal article
IGF-binding proteins secreted by cancer-associated fibroblasts induce context-dependent drug sensitization of lung cancer cells.
- Published in:
- Science Signaling, 2022, v. 15, n. 747, p. 1, doi. 10.1126/scisignal.abj5879
- By:
- Publication type:
- Article
ZEB1 Mediates Acquired Resistance to the Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer.
- Published in:
- PLoS ONE, 2016, v. 11, n. 1, p. 1, doi. 10.1371/journal.pone.0147344
- By:
- Publication type:
- Article
Network models of protein phosphorylation, acetylation, and ubiquitination connect metabolic and cell signaling pathways in lung cancer.
- Published in:
- PLoS Computational Biology, 2023, v. 19, n. 3, p. 1, doi. 10.1371/journal.pcbi.1010690
- By:
- Publication type:
- Article
Interleukin polymorphisms associated with overall survival, disease-free survival, and recurrence in non-small cell lung cancer patients.
- Published in:
- Molecular Carcinogenesis, 2015, v. 54, p. E172, doi. 10.1002/mc.22275
- By:
- Publication type:
- Article
From modules to medicine: How modular domains and their associated networks can enable personalized medicine
- Published in:
- FEBS Letters, 2012, v. 586, n. 17, p. 2580, doi. 10.1016/j.febslet.2012.04.036
- By:
- Publication type:
- Article
Clinicopathologic features and outcomes of patients with lung adenocarcinomas harboring BRAF mutations in the Lung Cancer Mutation Consortium.
- Published in:
- Cancer (0008543X), 2015, v. 121, n. 3, p. 448, doi. 10.1002/cncr.29042
- By:
- Publication type:
- Article
Safety, pharmacokinetics, and pharmacodynamics of oral omaveloxolone (RTA 408), a synthetic triterpenoid, in a first-in-human trial of patients with advanced solid tumors.
- Published in:
- OncoTargets & Therapy, 2017, v. 10, p. 4239, doi. 10.2147/OTT.S136992
- By:
- Publication type:
- Article
Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs.
- Published in:
- JAMA: Journal of the American Medical Association, 2014, v. 311, n. 19, p. 1998, doi. 10.1001/jama.2014.3741
- By:
- Publication type:
- Article
Preventing smoking relapse in patients with cancer: A randomized controlled trial.
- Published in:
- Cancer (0008543X), 2020, v. 126, n. 23, p. 5165, doi. 10.1002/cncr.33162
- By:
- Publication type:
- Article
A chemical and phosphoproteomic characterization of dasatinib action in lung cancer.
- Published in:
- Nature Chemical Biology, 2010, v. 6, n. 4, p. 291, doi. 10.1038/nchembio.332
- By:
- Publication type:
- Article
GMSimpute: a generalized two-step Lasso approach to impute missing values in label-free mass spectrum analysis.
- Published in:
- Bioinformatics, 2020, v. 36, n. 1, p. 257, doi. 10.1093/bioinformatics/btz488
- By:
- Publication type:
- Article
IPEP: an in silico tool to examine proteolytic peptides for mass spectrometry.
- Published in:
- Bioinformatics, 2008, v. 24, n. 23, p. 2801
- By:
- Publication type:
- Article
Role of LKB1-CRTC1 on glycosylated COX-2 and response to COX-2 inhibition in lung cancer.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Role of LKB1-CRTC1 on Glycosylated COX-2 and Response to COX-2 Inhibition in Lung Cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2014, v. 107, n. 1, p. 1, doi. 10.1093/jnci/dju358
- By:
- Publication type:
- Article